Mergers & Acquisitions ·
Niki BioSolutions, Inc. (formerly Aptorum Group Limited) consummated its merger with DiamiR Biosciences Corp. on July…
NIKINiki BioSolutions, Inc.
Niki BioSolutions, Inc. (formerly Aptorum Group Limited) consummated its merger with DiamiR Biosciences Corp. on July 20, 2026, following a domestication to Delaware and a name change. Concurrently, the company effected a one-for-10 reverse stock split effective July 20, 2026. The filing furnishes unaudited interim consolidated financial statements for the six months ended June 30, 2026, reporting a net loss of $1,307,300 and cash on hand of $1,834,171. Management has identified substantial doubt about the company's ability to continue as a going concern due to recurring losses and negative operating cash flows. The biopharmaceutical company researches and develops life science and therapeutic products.